(Q38578940)

English

The dual and opposite role of the TM6SF2-rs58542926 variant in protecting against cardiovascular disease and conferring risk for nonalcoholic fatty liver: A meta-analysis

scientific article published on September 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 September 2017

0 references

The dual and opposite role of the TM6SF2-rs58542926 variant in protecting against cardiovascular disease and conferring risk for nonalcoholic fatty liver: A meta-analysis (English)

1 reference

Europe PubMed Central

4 September 2017

cardiovascular disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Carlos J Pirola

1

1 reference

Europe PubMed Central

4 September 2017

Silvia Sookoian

2

1 reference

Europe PubMed Central

4 September 2017

language of work or name

0 references

publication date

1 September 2015

1 reference

Europe PubMed Central

4 September 2017

1 reference

Europe PubMed Central

4 September 2017

62

1 reference

Europe PubMed Central

4 September 2017

6

1 reference

Europe PubMed Central

4 September 2017

1742-1756

1 reference

Europe PubMed Central

4 September 2017

Heart disease and stroke statistics--2014 update: a report from the American Heart Association

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

21 January 2018

Major lipids, apolipoproteins, and risk of vascular disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

21 January 2018

Lipid parameters for measuring risk of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

21 January 2018

Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

21 January 2018

Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

21 January 2018

The global NAFLD epidemic

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

21 January 2018

Fatty liver: a novel component of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

21 January 2018

Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

21 January 2018

Liver transcriptional profile of atherosclerosis-related genes in human nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

21 January 2018

Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

21 January 2018

Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

21 January 2018

Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population-based study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

21 January 2018

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

21 January 2018

Large-scale association analysis identifies new risk loci for coronary artery disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

21 January 2018

Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

21 January 2018

Biological, clinical and population relevance of 95 loci for blood lipids

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

21 January 2018

Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

21 January 2018

Discovery and refinement of loci associated with lipid levels

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

21 January 2018

Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

21 January 2018

Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

21 January 2018

Prevalence of the TM6SF2 variant and non-alcoholic fatty liver disease in Chinese

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

21 January 2018

TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

21 January 2018

Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

21 January 2018

TM6SF2 Glu167Lys polymorphism is associated with low levels of LDL-cholesterol and increased liver injury in obese children

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

21 January 2018

Paradoxical dissociation between hepatic fat content and de novo lipogenesis due to PNPLA3 sequence variant.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

21 January 2018

Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

21 January 2018

Heterogeneity in meta-analyses of genome-wide association investigations

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

21 January 2018

Distribution of allele frequencies and effect sizes and their interrelationships for common genetic susceptibility variants

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

21 January 2018

An evolutionary framework for common diseases: the ancestral-susceptibility model

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

21 January 2018

Current perspectives on statins

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

21 January 2018

Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

21 January 2018

Mendelian randomization of blood lipids for coronary heart disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

21 January 2018

Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

21 January 2018

Cardiovascular and systemic risk in nonalcoholic fatty liver disease - atherosclerosis as a major player in the natural course of NAFLD.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

21 January 2018

Disease-associated alleles in genome-wide association studies are enriched for derived low frequency alleles relative to HapMap and neutral expectations

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

21 January 2018

Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

21 January 2018

Genetic variation in transmembrane 6 superfamily member 2 and the risk of nonalcoholic fatty liver disease and histological disease severity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

7 January 2021

based on heuristic

inferred from DOI database lookup

TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

7 January 2021

based on heuristic

inferred from DOI database lookup

The TM6SF2 rs58542926 T allele is significantly associated with non-alcoholic fatty liver disease in Chinese

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis: Its strengths and limitations.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutations in STAP1 are associated with autosomal dominant hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

7 January 2021

based on heuristic

inferred from DOI database lookup

Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28142

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.28142

1 reference

Europe PubMed Central

4 September 2017

1 reference

Europe PubMed Central

4 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38578940&oldid=1768612664"